ATHN CV

Enter your search criteria to find works by title, author, publication, keyword(s), or date.

Back

ATHN 2

FACTOR UTILISATION IN PATIENTS WITH HAEMOPHILIA A AFTER SWITCHING TO RURIOCTOCOG ALFA PEGOL IN THE ATHN 2 STUDY

Authors:
Journeycake, J., Caicedo, J., Cheng, D., Denne, M., Guelcher, C., Lattimore, S., Mokdad, A., Ragni, M., Recht, M., Sidonio, R., Takemoto, C., Tarantino, M., Watson, C., Neufeld, E.
Publication:
European Association for Haemophilia and Allied Disorders (EAHAD) Virtual Congress
Date:
February 3, 2021
Topics:
Hemophilia, Factor
Visit Publication

Clinical Outcomes in Patients with Haemophilia A After Switching to Rurioctocog Alfa Pegol Prophylaxis in the ATHN 2 Study

Authors:
Journeycake, J., Caicedo, J., Cheng, D., Denne, M., Guelcher, C., Lattimore, S., Mokdad, A., Ragni, M., Recht, M., Sidonio, R., Takemoto, C., Tarantino, M., Watson, C., Neufeld, E.
Publication:
European Association for Haemophilia and Allied Disorders (EAHAD) Virtual Congress
Date:
February 3, 2021
Topics:
Hemophilia, Factor
Visit Publication

Dosing, Patient Satisfaction, and Other Patient-Reported Outcomes After Switching to Rurioctocog Alfa Pegol in ATHN 2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Coagulation Replacement Factor Products

Authors:
Journeycake, J., Caicedo, J., Cheng, D., Denne, M., Guelcher, C., Lattimore, S., Ragni, M., Recht, M., Sidonio, R., Takemoto, C., Tarantino, M., Watson, C., Neufeld, EJ.
Publication:
ASH 2020
Date:
November 5, 2020
Topics:
Hemophilia, Factor
Visit Publication

Lack of inhibitor development after switching to antihemophilic factor (recombinant), pegylated in the American Thrombosis and Hemostasis Network (ATHN) 2: Factor Switching Study

Authors:
Journeycake, J., Cheng, D., Guelcher, C., Lattimore, S., Ragni, M., Recht, M., Sidonio, R., Takemoto, C., Tarantino, M., Watson, C., Neufeld, EJ.
Publication:
International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress
Date:
July 11-14, 2020
Topics:
Hemophilia, Inhibitor
Visit Publication

Lack of inhibitor development after switching to antihemophilic factor (recombinant), pegylated in the American Thrombosis and Hemostasis Network (ATHN) 2: Factor Switching Study

Authors:
Sidonio R., Cheng, D., Guelcher, C., Journeycake, J., Lattimore, S., Takemoto, C., Tarantino, MD., Watson, C., Neufeld, EJ., ATHN 2 Investigators.
Publication:
American Society of Hematology (ASH) 61st Annual Meeting, Orlando, FL
Date:
December 7-10, 2019
Topics:
Hemophilia, Inhibitor
Visit Publication

A Real-World Assessment of New Coagulation Factors through the American Thrombosis and Hemostasis Network (ATHN): ATHN 2: Factor Switching Study

Authors:
Neufeld, EJ., Journeycake, J., Aschman, D., Cheng, D., McCarthy, EG., Watson, C., ATHN 2 Steering Committee.
Publication:
HTRS 2017 Scientific Symposium, Scottsdale, AZ
Date:
April 6-8, 2017
Topics:
Hemophilia, Factor
Visit Publication

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.